RECIPROCAL CHANGES IN COMPLEMENT ACTIVITY AND IMMUNE-COMPLEX LEVELS DURING PLASMA INFUSION IN A C2-DEFICIENT SLE PATIENT

被引:21
作者
ERLENDSSON, K [1 ]
TRAUSTADOTTIR, K [1 ]
FREYSDOTTIR, J [1 ]
STEINSSON, K [1 ]
JONSDOTTIR, I [1 ]
VALDIMARSSON, H [1 ]
机构
[1] NATL UNIV REYKJAVIK, LANDSPITALI, DEPT INTERNAL MED, REYKJAVIK, ICELAND
关键词
C2; DEFICIENCY; IMMUNE COMPLEX CLEARANCE; PLASMA THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; IMMUNE COMPLEXES;
D O I
10.1177/096120339300200306
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although systemic lupus erythematosus (SLE) is abnormally common in individuals with complement deficiency, conclusive evidence has been lacking for a direct causal relationship between disease manifestations and a missing complement component. A patient with C2 deficiency and SLE has been treated with 56 courses of fresh frozen plasma (FFP) infusions over a period of 8 years. Each infusion, involving a total of 12 units of FFP administered in equal doses over 4 consecutive days, has consistently resulted in a transient restoration of the classical pathway of complement, and a full clinical remission lasting 6-8 weeks. This report is concerned with changes in the levels of immune complexes, C2 and C3d during an infusion cycle. Four progressively rising peaks in C2 and C3d were observed during the 4 days of the plasma infusion, and these peaks coincided with four reciprocally descending troughs in the levels of immune complexes. Identical fluctuations have been consistent in all the plasma-infusion cycles that have so far been monitored, and their consistent association with clinical remissions indicates a causal relationship between the C2 restoration and clinical remissons in this C2-deficient SLE patient.
引用
收藏
页码:161 / 165
页数:5
相关论文
共 31 条
[1]   LUPUS DISEASES ASSOCIATED WITH HEREDITARY AND ACQUIRED DEFICIENCIES OF COMPLEMENT [J].
AGNELLO, V .
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1986, 9 (2-3) :161-178
[2]  
AGNELLO V, 1978, MEDICINE, V57, P1
[3]   CIRCULATING IMMUNE-COMPLEXES - THEIR IMMUNOCHEMISTRY, DETECTION, AND IMPORTANCE [J].
BARNETT, EV ;
KNUTSON, DW ;
ABRASS, CK ;
CHIA, DS ;
YOUNG, LS ;
LIEBLING, MR .
ANNALS OF INTERNAL MEDICINE, 1979, 91 (03) :430-440
[4]  
Brandslund I, 1981, Methods Enzymol, V74 Pt C, P551
[5]   PRIMATE ERYTHROCYTE-IMMUNE COMPLEX-CLEARING MECHANISM [J].
CORNACOFF, JB ;
HEBERT, LA ;
SMEAD, WL ;
VANAMAN, ME ;
BIRMINGHAM, DJ ;
WAXMAN, FJ .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (02) :236-247
[6]   ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) QUANTITATIVE ASSAY OF IMMUNOGLOBULIN-G [J].
ENGVALL, E ;
PERLMANN, P .
IMMUNOCHEMISTRY, 1971, 8 (09) :871-&
[7]  
FREYSDOTTIR J, UNPUB
[8]   INCREASED AMOUNTS OF C4-CONTAINING IMMUNE-COMPLEXES AND INEFFICIENT ACTIVATION OF C3 AND THE TERMINAL COMPLEMENT PATHWAY IN A PATIENT WITH HOMOZYGOUS C2 DEFICIENCY AND SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
GARRED, P ;
MOLLNES, TE ;
THORSTEINSSON, L ;
ERLENDSSON, K ;
STEINSSON, K .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1990, 31 (01) :59-64
[9]  
HONG K, 1984, J IMMUNOL, V133, P1464
[10]  
LACHMANN PJ, 1987, AUTOIMMUNITY AUTOIMM, P149